{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:38:24Z","timestamp":1758807504301},"reference-count":40,"publisher":"Impact Journals, LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"DOI":"10.18632\/aging.205726","type":"journal-article","created":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T17:17:32Z","timestamp":1712337452000},"source":"Crossref","is-referenced-by-count":2,"title":["Clinical characteristics and prognostic analysis of primary extranodal non-Hodgkin lymphoma of the head and neck"],"prefix":"10.18632","author":[{"given":"Jiamu","family":"Lv","sequence":"first","affiliation":[{"name":"Department of Otolaryngology Head and Neck Surgery, First Hospital of Jilin University, Changchun, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yining","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, First Hospital of Jilin University, Changchun, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology Head and Neck Surgery, First Hospital of Jilin University, Changchun, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengrui","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology Head and Neck Surgery, First Hospital of Jilin University, Changchun, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanzhong","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology Head and Neck Surgery, First Hospital of Jilin University, Changchun, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2024,4,5]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1023\/a:1008313229892","article-title":"Primary extranodal non-Hodgkin\u2019s lymphomas. Part 2: Head and neck, central nervous system and other less common sites.","volume":"1","author":"Cavalli","year":"1999","journal-title":"Ann Oncol"},{"key":"2","doi-asserted-by":"publisher","first-page":"4936099","DOI":"10.1155\/2022\/4936099","article-title":"Analysis of the Clinicopathologic Characteristics and Prognosis of Head and Neck Lymphoma.","volume":"202","author":"Li","year":"2022","journal-title":"Anal Cell Pathol (Amst)"},{"key":"3","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1186\/1471-2407-14-764","article-title":"Racial differences in mantle cell lymphoma in the United States.","volume":"1","author":"Ma","year":"2014","journal-title":"BMC Cancer"},{"key":"4","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1023\/a:1008282818705","article-title":"Primary extranodal non-Hodgkin\u2019s lymphomas. Part 1: Gastrointestinal, cutaneous and genitourinary lymphomas.","volume":"8","author":"Cavalli","year":"1997","journal-title":"Ann Oncol"},{"key":"5","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1080\/02841860500531682","article-title":"Epidemiology and etiology of non-Hodgkin lymphoma--a review.","volume":"4","author":"Ekstr\u00f6m-Smedby","year":"2006","journal-title":"Acta Oncol"},{"key":"6","first-page":"181","article-title":"Integrating understanding of epidemiology and genomics in B-cell non-Hodgkin lymphoma as a pathway to novel management strategies.","volume":"2","author":"Koff","year":"2016","journal-title":"Discov Med"},{"key":"7","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1177\/014556131209100113","article-title":"Primary extranodal T-cell non-Hodgkin lymphoma of the tongue.","volume":"9","author":"Gopalakrishnan","year":"2012","journal-title":"Ear Nose Throat J"},{"key":"8","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1001\/archotol.1997.01900120068011","article-title":"Extranodal lymphomas of the head and neck. A 20-year experience.","volume":"12","author":"Lavertu","year":"1997","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.anorl.2014.07.005","article-title":"Extranodal lymphoma of the head and neck: a 67-case series.","volume":"13","author":"Bach","year":"2015","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"key":"10","doi-asserted-by":"publisher","first-page":"66","DOI":"10.5114\/wo.2017.66659","article-title":"Head and neck lymphomas - a retrospective ten-year observation.","volume":"2","author":"\u015acierski","year":"2017","journal-title":"Contemp Oncol (Pozn)"},{"key":"11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13005-018-0186-0","article-title":"Clinical presentation and characteristics of lymphoma in the head and neck region.","volume":"1","author":"Knopf","year":"2019","journal-title":"Head Face Med"},{"key":"12","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.4103\/jfmpc.jfmpc_1037_19","article-title":"Non-Hodgkin\u2019s lymphoma: A review.","volume":"9","author":"Sharma","year":"2020","journal-title":"J Family Med Prim Care"},{"key":"13","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.kjms.2012.02.014","article-title":"Head and neck extranodal lymphoma in a single institute: a 17-year retrospective analysis.","volume":"2","author":"Kuo","year":"2012","journal-title":"Kaohsiung J Med Sci"},{"key":"14","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1017\/S0022215113001217","article-title":"Characteristics and prognostic factors for head and neck non-Hodgkin\u2019s lymphoma in Chinese patients.","volume":"12","author":"Wang","year":"2013","journal-title":"J Laryngol Otol"},{"key":"15","doi-asserted-by":"publisher","first-page":"103237","DOI":"10.1016\/j.critrevonc.2021.103237","article-title":"Extranodal NK\/T cell lymphoma, nasal type: An updated overview.","volume":"15","author":"Carlos","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"key":"16","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1038\/s41375-021-01313-2","article-title":"NK-\/T-cell lymphomas.","volume":"3","author":"Liang","year":"2021","journal-title":"Leukemia"},{"key":"17","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1002\/alr.23102","article-title":"Primary sinonasal lymphoma: A multi-institutional experience of clinical presentation, treatment, and outcomes.","volume":"1","author":"Kuan","year":"2023","journal-title":"Int Forum Allergy Rhinol"},{"key":"18","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms.","volume":"12","author":"Jaffe","year":"2016","journal-title":"Blood"},{"key":"19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13000-019-0856-7","article-title":"Prognostic impact of diffuse large B-cell lymphoma with extra copies of MYC, BCL2 and\/or BCL6: comparison with double\/triple hit lymphoma and double expressor lymphoma.","volume":"1","author":"Li","year":"2019","journal-title":"Diagn Pathol"},{"key":"20","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.","volume":"10","author":"Smith","year":"2004","journal-title":"Blood"},{"key":"21","first-page":"43","article-title":"The staging of non-Hodgkin\u2019s lymphomas.","volume":"1","author":"Golomb","year":"1990","journal-title":"Semin Oncol"},{"key":"22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1601-0825.2009.01586.x","article-title":"Malignant lymphoma of the head and neck.","volume":"1","author":"Basterra","year":"2010","journal-title":"Oral Dis"},{"key":"23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/cncr.10922","article-title":"Cytologic and immunocytochemical findings of anaplastic large cell lymphoma: analysis of ten fine-needle aspiration specimens over a 9-year period.","volume":"9","author":"Collins","year":"2003","journal-title":"Cancer"},{"key":"24","doi-asserted-by":"publisher","first-page":"NP591","DOI":"10.1177\/01455613211031024","article-title":"Nasal Maggot Infection in a Patient With Nasal Non-Hodgkin\u2019s Lymphoma.","volume":"10","author":"Huang","year":"2023","journal-title":"Ear Nose Throat J"},{"key":"25","first-page":"661","article-title":"Malignancy in asymmetrical but otherwise normal palatine tonsils.","volume":"8","author":"Sipaul","year":"2006","journal-title":"Ear Nose Throat J"},{"key":"26","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3760\/cma.j.cn112152-20210516-00382","article-title":"[Clinical practice guideline for lympoma in China (2021 Edition)].","volume":"4","author":"China Anti-cancer Association Lymphoma Committee, Chinese Association for Clinical Oncologists","year":"2021","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"27","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/hed.1077","article-title":"Localized non-Hodgkin\u2019s lymphoma of Waldeyer\u2019s ring: clinical features, management, and prognosis of 130 adult patients.","volume":"2","author":"Zucca","year":"2001","journal-title":"Head Neck"},{"key":"28","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.clon.2003.10.010","article-title":"Localised extranodal lymphoma of the head and neck: the Sheffield Lymphoma Group experience (1971-2000).","volume":"1","author":"Hancock","year":"2004","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"29","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.4103\/jcrt.JCRT_213_20","article-title":"Lymphomas of the head-and-neck region.","volume":"1","author":"Kami\u0144ski","year":"2021","journal-title":"J Cancer Res Ther"},{"key":"30","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.pathol.2017.09.006","article-title":"Diffuse large B-cell lymphoma.","volume":"5","author":"Medeiros","year":"2018","journal-title":"Pathology"},{"key":"31","doi-asserted-by":"publisher","first-page":"938","DOI":"10.3390\/cancers12040938","article-title":"BCL-2 Proteins in Pathogenesis and Therapy of B-Cell Non-Hodgkin Lymphomas.","volume":"1","author":"Klener","year":"2020","journal-title":"Cancers (Basel)"},{"key":"32","doi-asserted-by":"publisher","first-page":"136","DOI":"10.19746\/j.cnki.issn.1009-2137.2022.01.022","article-title":"[Correlation and Influencing Factors of SUVmax and Ki-67 in Non-Hodgkin Lymphoma].","volume":"3","author":"Ma","year":"2022","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"33","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1200\/JCO.1999.17.1.268","article-title":"Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy.","volume":"1","author":"Varns","year":"1999","journal-title":"J Clin Oncol"},{"key":"34","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1200\/JCO.2001.19.2.389","article-title":"Phase II study of rituximab in combination with chop chemotherapy in patients with previously untreated, aggressive non-Hodgkin\u2019s lymphoma.","volume":"1","author":"Fisher","year":"2001","journal-title":"J Clin Oncol"},{"key":"35","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.","volume":"34","author":"Gisselbrecht","year":"2002","journal-title":"N Engl J Med"},{"key":"36","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/S1470-2045(06)70664-7","article-title":"CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group.","volume":"7","author":"Shpilberg","year":"2006","journal-title":"Lancet Oncol"},{"key":"37","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.radonc.2011.05.013","article-title":"Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial.","volume":"10","author":"Hoskin","year":"2011","journal-title":"Radiother Oncol"},{"key":"38","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/s11864-014-0286-4","article-title":"Radiotherapy of follicular lymphoma: updated role and new rules.","volume":"1","author":"Yahalom","year":"2014","journal-title":"Curr Treat Options Oncol"},{"key":"39","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1177\/00034894211025171","article-title":"Extranodal Head and Neck Mantle Cell Lymphoma: Characteristics, Treatment, and Survival.","volume":"13","author":"Kohli","year":"2022","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"40","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s11864-004-0021-7","article-title":"Primary thyroid lymphomas.","volume":"5","author":"Pasieka","year":"2004","journal-title":"Curr Treat Options Oncol"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205726","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T17:18:39Z","timestamp":1712337519000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,5]]},"references-count":40,"alternative-id":["205726"],"URL":"https:\/\/doi.org\/10.18632\/aging.205726","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,5]]}}}